ArticleInfectious diseases of poverty2025
Risk factor for gametocyte carriage and gametocytemia in Plasmodium vivax and Plasmodium falciparum.
Article in Infectious diseases of poverty, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Spatiotemporal differentiation of Plasmodium vivax populations in the western Greater Mekong Subregion using a 22-SNP barcode.PLoS neglected tropical diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
Abstract
backgroundUnderstanding Plasmodium sexual differentiation is crucial for blocking transmission. This study identified risk factors for gametocyte carriage and gametocytemia in P. vivax and P. falciparum to inform malaria elimination strategies at the China-Myanmar border.
methodsGametocytes and asexual parasites were microscopically detected on thick smears collected from 2011 to 2020 in Laiza Township, Kachin State, Myanmar. Mono-/polyclonality were detected by genotyping at Pvmsp3α/β for P. vivax, and Pfmsp1/2 for P. falciparum. Kulldorff's retrospective time scan statistics tested for likely clusters of gametocyte-positive cases over time. Chi-square or Fisher's exact tests compared proportions of gametocyte-positive cases in categorical variables. Generalized linear models assessed risk factors (year, season, demographics, clinical/parasitological features) for gametocyte carriage (logistic regression for a binomial outcome) and gametocytemia (Gaussian regression for continuous outcome), respectively.
resultsDuring 2011-2020, 8240 patients had P. vivax infections, with 7249 testing positive for gametocytes. Among 510 P. falciparum cases, 56 tested positive for gametocytes. A significant cluster of P. vivax gametocyte carriage occurred from May 2015 to August 2017 (P = 0.001). For P. vivax, dry season, previous malaria history, fever, and parasite density were associated with gametocyte carriage. Gametocyte density increased with asexual parasite density (P < 0.001) but was lower during the rainy season and in those with a history of malaria infection (P < 0.001). Over time, gametocytes carriage proportion increased while density decreased (P < 0.001). For P. falciparum, younger age and previous malaria history were associated with gametocyte carriage, and density was higher in the dry season (P = 0.0115). Polyclonal P. vivax infections had higher gametocyte densities than monoclonal infections (P < 0.0001) and P. falciparum gametocyte density tended to increase with multiplicity of infection.
conclusionsYounger age, prior malaria infection, travel, and polyclonal infections correlate with higher P. vivax gametocyte prevalence. Gametocyte carriage peakes during the dry season, highlighting the need for seasonal strategies to support malaria elimination. These findings enhance understanding of risk factors for the transmissible stage of the two main human Plasmodium species in the Greater Mekong Subregion border areas.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.